Biomarkers for Hepatocellular Carcinoma
The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and carries a poor survival rate. The management of patients at risk for developing HCC remains challenging. Increased understanding of cancer biology and technological advances have enabled identification of a multitude o...
Saved in:
Main Authors: | Tara Behne, M. Sitki Copur |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2012/859076 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma
by: Yangyang Zhang, et al.
Published: (2022-01-01) -
NOL-7 serves as a potential prognostic-related biomarker for hepatocellular carcinoma
by: Qiucheng Lei, et al.
Published: (2025-01-01) -
Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials
by: Christina Michailidi, et al.
Published: (2014-01-01) -
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
by: San-Chi Chen, et al.
Published: (2025-02-01) -
TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
by: Sheng Cheng, et al.
Published: (2023-01-01)